申请人:THERAVANCE BIOPHARMA R&D IP, LLC
公开号:US10123984B2
公开(公告)日:2018-11-13
In one aspect, the invention relates to compounds having the formula:
where R1-R6, a, b, and Z are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have neprilysin inhibition activity. In another aspect, the invention relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and processes and intermediates for preparing such compounds.
一方面,本发明涉及具有以下式子的化合物:
其中 R1-R6、a、b 和 Z 如说明书中所定义,或其药学上可接受的盐。这些化合物具有肾酶抑制活性。在另一方面,本发明涉及包含此类化合物的药物组合物;使用此类化合物的方法;以及制备此类化合物的工艺和中间体。